Research article · 17 Mar 2020
Conference abstract
Dissolution method development: RandD and QC holding hands
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Dissolution is an analytical test commonly used by the pharmaceutical industry to guide both formulation design and drug product quality control. When considering the development of a dissolution method, two main goals must be considered: 1) ensure consistent lot-to-lot quality for commercial products; 2) be suitable as QC tool for daily routine. The traditional dissolution approach often emphasizes its application in quality control testing and usually strives to obtain 100% drug release. In the presence of two oral granules formulations, with in-vivo data available, that showed differences in bioavalability, the initial method development was focused on a traditional dissolution approach. However, results showed that the method used had no disciminatory effect, therefore not reflecting the in-vivo data. A biorelevant dissolution method development followed - a pH shift method, where for the initial 30 minutes a low pH was applied followed by 90 minutes of neutral pH, was undertaken. The goal was to mimic the pH differences throughout the gastric system. The pH adjustment had been previously tested to ensure that the addition of NaOH 1M and PBS would shift the pH 1 to pH 7. The development of a robust method, that allowed the correlation with in-vivo data was successfully achieved and discrimination between prototypes was accomplished. The current work also shows that with proper development, pH shift dissolution methods can suit early development and routine QC lab needs.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Research article · 3 May 2019
Development and validation of a RP-HPLC-PDA method for simultaneous estimation of Drotaverine and Etoricoxib in tablet and its application for dissolution studies
Research article · 3 May 2019
Development and validation of RP-HPLC method for nifedipine and its application for a novel proniosomal formulation analysis and dissolution study
Research article · 31 May 2018
Dissolution Method Development and Validation for Tablet Dosage form of Telmisartan Using UV Spectrophotometric Method
Research article · 6 Nov 2017
Stabity indicating Dissolution Method Development for Estimation of Paracetamol and Chlorzoxazone in Combine Dosage form
More from this journal
The newest in Pharmaceutica Analytica Acta.
Article · 16 Sep 2026
The Fc Domains in the Monoclonal Antibody and Fusion Protein Significantly Boost the Biocomposite Suspension's Power to Combat Harmful Microorganisms, Enhance Drug Delivery, and Improve Protein Stability
Article · 26 Jun 2026
Green Pathways in Drug Quality Assessment: The Growing Role of Sustainable Pharmaceutical Analytics
Article · 26 Jun 2026
Advanced Single-Cell Signal Analysis: The Role of Ghost Cytometry in Cell Therapy Characterization
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalPharmaceutica Analytica Acta
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Ana Mafalda Paiva”
- BylineArticles whose byline prints “Constanca Cacela”

